Directive 2001/83/EC of the European Parliament and of the CouncilShow full title

Article 90 U.K.

The advertising of a medicinal product to the general public shall not contain any material which:

(a)

gives the impression that a medical consultation or surgical operation is unnecessary, in particular by offering a diagnosis or by suggesting treatment by mail;

(b)

suggests that the effects of taking the medicine are guaranteed, are unaccompanied by adverse reactions or are better than, or equivalent to, those of another treatment or medicinal product;

(c)

suggests that the health of the subject can be enhanced by taking the medicine;

(d)

suggests that the health of the subject could be affected by not taking the medicine; this prohibition shall not apply to the vaccination campaigns referred to in Article 88(4);

(e)

is directed exclusively or principally at children;

(f)

refers to a recommendation by scientists, health professionals or persons who are neither of the foregoing but who, because of their celebrity, could encourage the consumption of medicinal products;

(g)

suggests that the medicinal product is a foodstuff, cosmetic or other consumer product;

(h)

suggests that the safety or efficacy of the medicinal product is due to the fact that it is natural;

(i)

could, by a description or detailed representation of a case history, lead to erroneous self-diagnosis;

(j)

refers, in improper, alarming or misleading terms, to claims of recovery;

(k)

uses, in improper, alarming or misleading terms, pictorial representations of changes in the human body caused by disease or injury, or of the action of a medicinal product on the human body or parts thereof[F1 .]

(l)

[F2 . . . . .]

Textual Amendments

F1 Substituted by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use.

F2 Deleted by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use.